Speaker illustration

Doctor Michel Farnier

University of Bourgogne Franche Comte, Dijon (France)

Change of paradigm in dyslipidemia management

Event: ESC Congress 2022

Topic: Lipids

Session type: Satellite Symposium

Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk